Doctors Note Logo

Published on: 4/28/2026

How Anti-VEGF Injections Stop Vision Loss in Diabetics

Anti-VEGF injections transformed diabetic retinopathy treatment by blocking VEGF to reduce retinal vessel leakage and prevent abnormal vessel growth, helping preserve and sometimes improve vision.

There are several important factors to consider, including injection schedules, possible side effects, monitoring requirements, and diabetes management. See complete details below to understand what to expect and which next steps might be best for your care.

answer background

Explanation

How Anti-VEGF Injections Stop Vision Loss in Diabetics

Diabetic retinopathy is a leading cause of vision loss among people with diabetes. High blood sugar levels can damage the small blood vessels in the retina, leading to leakage, swelling and the growth of fragile new vessels. Without treatment, this damage can progress to serious vision impairment or blindness.

Anti-VEGF injections have transformed care for diabetic retinopathy. By targeting vascular endothelial growth factor (VEGF), these treatments reduce leakage and abnormal vessel growth, helping to preserve—and sometimes improve—vision.

Understanding VEGF and Its Role in Diabetic Retinopathy

VEGF is a protein that stimulates the formation of new blood vessels (angiogenesis). In diabetes, chronic high glucose levels:

  • Damages retinal capillaries
  • Triggers inflammation and hypoxia (low oxygen)
  • Causes the retina to release excess VEGF

Excess VEGF leads to:

  • Growth of fragile, abnormal blood vessels (neovascularization)
  • Fluid leakage into the macula (diabetic macular edema)
  • Progressive vision loss

By blocking VEGF, anti-VEGF injections halt these processes.

What Are Anti-VEGF Injections?

Anti-VEGF injections are medications delivered directly into the eye's vitreous cavity. Commonly used agents include:

  • Ranibizumab (Lucentis)
  • Aflibercept (Eylea)
  • Bevacizumab (Avastin) – often used off-label

These drugs bind to VEGF molecules, preventing them from attaching to receptors on blood vessel walls. As a result, they:

  • Reduce leakage from existing vessels
  • Prevent growth of new, fragile vessels
  • Promote stabilization or improvement of vision

The Injection Procedure

Anti-VEGF injections are outpatient treatments performed by an ophthalmologist:

  1. Preparation
    • Numbing drops or an injection of local anesthetic
    • Cleaning the eyelid area with antiseptic
  2. Injection
    • A fine needle delivers medication into the vitreous (gel) inside the eye
    • The procedure takes just a few minutes
  3. Aftercare
    • Mild pressure or antibiotic drops may be applied
    • You'll rest briefly before leaving
    • A follow-up appointment is scheduled

No stitches are needed. Most people experience only mild discomfort.

Treatment Schedule

A typical anti-VEGF regimen for diabetic retinopathy injections may include:

  • Loading phase: Injections every month for 3–6 months
  • Maintenance phase: Injections every 2–3 months, or as needed based on testing
  • Monitoring: Eye exams and imaging guide the frequency

Some protocols use "treat and extend," lengthening intervals when the retina remains stable.

Benefits of Anti-VEGF Therapy

Clinical studies show that anti-VEGF injections can:

  • Reduce macular swelling (diabetic macular edema)
  • Prevent further vision loss, even in advanced stages
  • Improve visual acuity in many patients
  • Decrease the need for laser surgery or vitrectomy

Compared with older treatments (laser photocoagulation), injections offer:

  • Faster visual improvement
  • Less damage to peripheral vision
  • A more targeted approach

Safety and Side Effects

Anti-VEGF injections are generally well tolerated. Possible side effects include:

Common (mild):

  • Redness or irritation around the eye
  • Floaters (tiny shadows drifting in vision)
  • Mild eye pain

Uncommon (serious):

  • Infection inside the eye (endophthalmitis)
  • Increased eye pressure
  • Retinal detachment

Your doctor will discuss risks and signs to watch for, such as:

  • Severe eye pain or vision changes
  • Eye redness with discharge
  • Sensitivity to light

Prompt medical attention can address complications early.

Monitoring Progress

Regular follow-up helps ensure the treatment is working:

  • Visual acuity tests track changes in sharpness of vision
  • Optical coherence tomography (OCT) measures retinal thickness and fluid
  • Fundus photography documents blood vessel changes

These assessments guide decisions about continuing, adjusting or extending injection intervals.

Living Well with Diabetic Retinopathy Injections

Combining injections with good diabetes management maximizes benefits:

  • Maintain healthy blood sugar (HbA1c) levels
  • Control blood pressure and cholesterol
  • Attend routine eye exams (at least once a year)
  • Adopt a balanced diet and exercise plan

Staying proactive helps protect your vision and overall health.

Check Your Symptoms

Early detection matters. If you have diabetes and notice blurred vision, floaters, or dark spots in your field of view, use our free AI-powered Diabetic Retinopathy symptom checker to understand your risk and determine if you should schedule a comprehensive eye exam.

When to Talk to Your Doctor

Anti-VEGF injections offer a powerful way to stop or slow vision loss in diabetic retinopathy. However, if you experience:

  • Sudden vision changes
  • Eye pain or swelling
  • Any symptoms of severe infection

…you should seek prompt medical care. Always speak to a doctor about anything that could be life-threatening or serious.

Your ophthalmologist can help tailor a treatment plan to your needs. Together, you can work toward preserving your vision and quality of life.

(References)

  • * El-SNH, et al. Anti-VEGF Therapy for Diabetic Retinopathy and Diabetic Macular Edema: A Review. *Cells*. 2021 Oct 21;10(11):2841. doi: 10.3390/cells10112841. PMID: 34831102; PMCID: PMC8615024.

  • * Zafar S, et al. Mechanism of Action of Anti-VEGF in Diabetic Macular Edema. *J Clin Med*. 2022 Nov 9;11(22):6626. doi: 10.3390/jcm11226626. PMID: 36431980; PMCID: PMC9692482.

  • * Ercan YKS, et al. Molecular Mechanisms of Anti-VEGF Treatment in Diabetic Retinopathy. *Int J Mol Sci*. 2023 Apr 19;24(8):7470. doi: 10.3390/ijms24087470. PMID: 37175850; PMCID: PMC10196887.

  • * Nogueira BB, et al. Vascular Endothelial Growth Factor and Diabetic Retinopathy: Pathophysiological Implications and Therapeutic Opportunities. *Front Endocrinol (Lausanne)*. 2022 Feb 14;13:836468. doi: 10.3389/fendo.2022.836468. PMID: 35237397; PMCID: PMC8884940.

  • * Cheetham JK, et al. Diabetic Retinopathy: From Pathophysiology to Novel Therapeutic Targets. *Int J Mol Sci*. 2023 Jul 26;24(15):12019. doi: 10.3390/ijms241512019. PMID: 37569106; PMCID: PMC10431388.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.